Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Nobel Laureate in Economics and Professor of Economics Paul Krugman Talks SCOTUS
07:09

California Attorney General Rob Bonta Talks Tariff Ruling
06:31

Middle East Geoeconomics Lead for Bloomberg Economics, Dina Esfandiary, Talks US Military, Middle East Tensions
07:38